Recent News
The Chase Group Drug Safety Expertise Utilized by Ionis Pharmaceuticals
As the leading innovator in RNA-targeted therapeutics, Ionis Pharmaceuticals requires world-class scientists and business leaders whose passion to innovate is matched only by their commitment… Continue Reading →
The Chase Group Acquiring Talent in Denmark
The Chase Group has been retained by Genmab in Copenhagen, Denmark, to continue building their drug safety team and is recruiting to secure a Director,… Continue Reading →
Immunology Institute: Expanding the Computational Biology Team to Directly Impact Human Health
The Allen Institute for Immunology recently launched a retained search, led by The Chase Group, dedicated to building the computational biology team at the Institute… Continue Reading →
Eisai, Inc. Cuts to the Chase for Their Recruiting Expertise in Global Medical Affairs, Oncology
A boutique firm working exclusively in life sciences, The Chase Group, with 25+ years’ executive search experience, can identify and deliver the highest quality executives… Continue Reading →
A New Era Begins with Head of Pathology Placement at Genmab
Dr. Suzana Couto joins Genmab Pharmaceuticals as Head of Pathology, leading the pathology teams located in Utrecht, Netherlands, and Princeton, New Jersey. This international biotechnology… Continue Reading →
Through Partnership With The Chase Group, Aeglea BioTherapeutics Continues Building Rare Disease Clinical Development Leadership Team
The Chase Group is honored to continue our partnership with Aeglea BioTherapeutics as we work to build their Rare Disease Clinical Development Leadership team. As… Continue Reading →
Data Science Leadership Team Set to Expand with The Chase Group/Genmab Partnership
The Chase Group is proud to be partnering with Genmab, a publicly traded, international, biotechnology company with the goal of transforming oncology research by discovering… Continue Reading →
Eli Lilly Partnership Continues in Medical Affairs Oncology
Eli Lilly continues to partner with The Chase Group to build the Medical Affairs Oncology team for their Cyramza® portfolio. The Chase Group is currently… Continue Reading →